CoreCap Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$43.7K Buy
83
+8
+11% +$4.49K ﹤0.01% 1464
2026
Q1
$42.1K Buy
75
+3
+4% +$1.92K ﹤0.01% 1378
2025
Q4
$48.7K Sell
72
-584
-89% -$398K ﹤0.01% 1349
2025
Q3
$419K Sell
656
-312
-32% -$189K 0.02% 564
2025
Q2
$519K Buy
968
+909
+1,541% +$435K 0.02% 507
2025
Q1
$24.8K Sell
59
-29
-33% -$12.6K ﹤0.01% 1451
2024
Q4
$36.4K Sell
88
-7
-7% -$3.07K ﹤0.01% 1313
2024
Q3
$48K Buy
95
+8
+9% +$3.89K ﹤0.01% 1207
2024
Q2
$42.4K Buy
87
+16
+23% +$8.03K ﹤0.01% 703
2024
Q1
$38.3K Buy
+71
New +$38.8K ﹤0.01% 1210
2022
Q4
$76.3K Buy
+187
New +$72.6K 0.01% 835
2022
Q3
Sell
-229
Closed -$80K 1236
2022
Q2
$80K Sell
229
-169
-42% -$68.9K 0.01% 768
2022
Q1
$218K Sell
398
-1,065
-73% -$560K 0.02% 489
2021
Q4
$963K Buy
+1,463
New +$918K 0.06% 232

Other funds holding IDXX

CoreCap Advisors's IDXX Position: Q2 2026 in Review

CoreCap Advisors increased its Idexx Laboratories (IDXX) stake by 11% in Q2 2026, buying an estimated $4.49K and bringing the position to 83 shares worth $43.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1464.

CoreCap Advisors first reported a position in IDXX in Q4 2021 and has held it in 14 quarters since. The position peaked at $963K in Q4 2021. 298 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • CoreCap Advisors held 83 shares of Idexx Laboratories worth $43.7K as of Q2 2026.
  • CoreCap Advisors bought 8 Idexx Laboratories shares in Q2 2026, an estimated $4.49K.
  • Idexx Laboratories made up ﹤0.01% of CoreCap Advisors's portfolio in Q2 2026, its #1464 holding.
  • CoreCap Advisors first reported a position in Idexx Laboratories in Q4 2021 and has held it in 14 quarters since.
  • CoreCap Advisors's Idexx Laboratories position peaked at $963K in Q4 2021.
  • 298 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on CoreCap Advisors's 13F filing for Q2 2026, filed 6 Jul 2026.